DANZITEN vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. DANZITEN and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DANZITEN	SIROLIMUS
Rating	70/100	66/100
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	NILOTINIB TARTRATE	SIROLIMUS
Manufacturer	Azurity	Apotex
Dosage forms	Tablet	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

danziten sirolimus

Rating

70/100

66/100

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

NILOTINIB TARTRATE

SIROLIMUS

Manufacturer

Azurity

Apotex

Dosage forms

Tablet

Solution

Drug class

Kinase Inhibitor

Boxed warning

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

Which is better-rated, Danziten or Sirolimus?

By our independent rating, Danziten scores higher — 3.5 vs 3.3 out of 5 for Sirolimus. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Danziten and Sirolimus?

Danziten contains Nilotinib Tartrate, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.